Alnylam Pharmaceuticals
ALNY
#582
Rank
$34.26 B
Marketcap
$264.74
Share price
-1.38%
Change (1 day)
72.66%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company